전기 의료 시장 : 제품별, 디바이스 유형별, 용도별, 최종사용자별 - 세계 기회 분석과 산업 예측(2023-2032년)

Electroceuticals Market By Product, By Device Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 7,980,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,370,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세계의 전기 의료 시장 규모는 2022년에 198억 달러에 달하며, 2023-2032년에 CAGR 7.4%로 성장하며, 2032년에는 405억 달러에 달할 것으로 예측되고 있습니다.

전기 의료는 치료 목적으로 신체의 신경 회로, 조직, 장기를 조절하기 위해 전기 자극을 이용하는 치료기입니다. 만성 통증, 신경 장애, 심혈관 질환 등 다양한 증상을 치료하기 위한 비약물학적 접근법을 제공합니다. 신체 자체의 전기 신호 전달 경로를 활용함으로써 전기 의료는 정상적인 생리적 기능을 회복하고 증상을 완화하는 것을 목표로 합니다. 이러한 장비는 이식형 신경 자극기 및 신경 조절 장비부터 경피적 전기 신경 자극(TENS) 장비 및 착용형 전기 치료 패치와 같은 외부 장비에 이르기까지 다양합니다. 전기 치료는 혁신적이고 빠르게 발전하고 있는 분야로, 환자의 결과와 삶의 질을 개선할 수 있는 유망한 솔루션을 제공합니다.

전기 의료 시장의 성장은 노인 인구 증가가 주요 요인으로 작용하고 있습니다. 이는 노인들이 신경 장애, 만성 통증, 심혈관계 질환 등 노화와 관련된 건강 상태에 걸리기 쉽다는 사실에 기인하며, 이는 종종 전기 치료기를 사용하여 치료할 수 있습니다. 미국 인구조사국(2022년)에 따르면 미국에는 65세 이상 성인이 5,600만 명 이상 거주하고 있으며, 이는 미국 인구의 거의 16.9%를 차지합니다. 또한 고령층은 약물 의존도를 최소화하고 삶의 질을 개선하기 위해 대체 요법을 찾고 있으며, 이는 전기 의료에 대한 수용성 확대로 이어지고 있습니다. 또한 헬스케어 기술의 발전과 신체의 전기 시스템에 대한 이해도가 높아짐에 따라 노인들의 요구에 맞는 혁신적인 전기 의료 솔루션의 길이 열리고 있습니다. 결과적으로 노인 인구 증가는 전기 의료 제조업체와 개발자에게 큰 시장 기회를 가져다주며, 이 분야에 대한 투자, 연구개발을 촉진하고 있습니다.

또한 전기 치료기는 주목할 만한 기술 발전이 이루어지고 있으며, 그 결과 더 작고 유연하며 효율적인 제품이 탄생하고 있습니다. 이러한 발전에는 MRI 스캔과의 호환성이 포함되며, 영상 처리 절차 중에 기기를 분리해야 하는 불편함이 사라졌습니다. 또한 충전식 배터리와 무선 기능의 도입으로 환자의 편안함과 편의성이 향상되고 있습니다. 이러한 기술 혁신은 환자의 이동성 및 사용 편의성과 같은 주요 관심사에 대응하여 환자와 의사 모두에 대한 수요를 주도하고 있습니다. 그 결과, 전기 의료 시장은 큰 성장을 이룰 것으로 예상됩니다. 이러한 발전으로 인해 이러한 기기들이 더욱 친숙하고 사용하기 쉬워지고, 다양한 질환에 대한 효과적인 치료를 제공할 수 있게 되어 궁극적으로 환자의 치료 결과와 삶의 질을 개선할 수 있기 때문입니다.

세계 전기 의료 시장은 제품, 기기 유형, 용도, 최종사용자, 지역으로 구분됩니다. 제품별로는 심장 박동기 및 이식형 제세동기, 인공와우, 척수 자극기, 뇌심부자극기, 미주신경 자극기, 천골신경 자극기, 기타로 분류됩니다. 디바이스 유형에 따라 이식형 디바이스와 비침습형 디바이스로 나뉩니다. 용도별로는 부정맥, 감음성 난청, 간질, 파킨슨병, 기타로 분류됩니다. 최종사용자별로는 병원, 외래수술센터(ASC), 기타로 분류됩니다. 지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽), 아시아태평양(중국, 일본, 인도, 인도, 호주, 한국, 기타 아시아태평양), 중남미(브라질, 콜롬비아, 아르헨티나, 기타 중남미), 중동 및 아프리카(GCC, 콜롬비아, 아르헨티나, 기타 중동 및 아프리카)로 분석됩니다.

이해관계자를 위한 주요 이점

• 이 보고서는 2022-2032년 전기 의료 시장 분석 시장 부문, 현재 동향, 추정 동향 및 역학을 정량적으로 분석하여 일반적인 전기 의료 시장 기회를 식별합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter's Five Forces 분석은 이해 관계자가 이익 중심의 비즈니스 결정을 내리고 공급자와 구매자의 네트워크를 강화할 수 있도록 구매자와 공급자의 잠재력을 밝힙니다.
• 전기 의료 시장의 세분화를 자세히 분석하여 시장 기회를 파악할 수 있습니다.
• 각 지역의 주요 국가는 세계 시장에 대한 매출 기여도에 따라 매핑되어 있습니다.
• 시장 기업의 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역 및 세계 전기 의료 시장 동향, 주요 기업, 시장 부문, 용도 및 시장 성장 전략에 대한 분석이 포함되어 있습니다.

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심사에 따른 기업 개요 추가
• 기업 개요 확장 리스트
• 과거 시장 데이터
• 상환 시나리오

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장의 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회

제4장 전기 의료 시장 : 제품별

• 개요
• 심장 페이스메이커·이식형 제세동기
• 인공와우
• 척수 자극기
• 뇌심부 자극기
• 미주신경 자극기
• 천골신경 자극기
• 기타

제5장 전기 의료 시장 : 디바이스 유형별

• 개요
• 이식형 디바이스
• 비침습성 디바이스

제6장 전기 의료 시장 : 용도별

• 개요
• 부정맥
• 감음성 난청
• 간질
• 파킨슨병
• 기타

제7장 전기 의료 시장 : 최종사용자별

• 개요
• 병원
• 외래 수술 센터
• 기타

제8장 전기 의료 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 콜롬비아
  • 아르헨티나
  • 기타 라틴아메리카
• 중동 및 아프리카
  • GCC
  • 남아프리카공화국
  • 북아프리카
  • 기타 중동 및 아프리카

제9장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2022년

제10장 기업 개요

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Cochlear Limited
• LivaNova PLC
• Biotronik SE & Co. KG
• electroCore, Inc.
• Sonova Holding AG
• Nevro Corporation
• Oticon Medical AB

KSA

영문 목차

영문목차

The global electroceuticals market was valued at $ 19.8 billion in 2022 and is estimated to reach $40.5 billion by 2032, exhibiting a CAGR of 7.4% from 2023 to 2032. Electroceuticals are medical devices that utilize electrical impulses to modulate the body's neural circuits, tissues, or organs for therapeutic purposes. They offer a non-pharmacological approach for treating various conditions such as chronic pain, neurological disorders, and cardiovascular diseases. By leveraging the body's own electrical signaling pathways, electroceuticals aim to restore normal physiological function and alleviate symptoms. These devices can range from implanted neurostimulators and neuromodulators to external devices such as transcutaneous electrical nerve stimulation (TENS) units and wearable electroceutical patches. Electroceuticals represent an innovative and rapidly advancing field, offering promising solutions for improving patient outcomes and quality of life.

The growth of the electroceuticals market is majorly driven by increase in geriatric population. This is attributed to the fact that elderly individuals are susceptible to age-related health conditions such as neurological disorders, chronic pain, and cardiovascular issues, which are often treated using electroceutical devices. As per the U.S. Census Bureau 2022, more than 56 million adults aged 65 and above live in the U.S., accounting for almost 16.9% of the nation's population; thus, rise in geriatric population is anticipated to fuel the growth of the market. In addition, the aging demographic seeks alternative treatments to minimize medication dependency and improve quality of life, leading to greater acceptance of electroceuticals. Moreover, advancements in healthcare technology and the growing understanding of the body's electrical systems have paved the way for innovative electroceutical solutions tailored to the needs of older adults. As a result, the expanding elderly population presents a significant market opportunity for electroceutical manufacturers and developers, driving investment, research, and development in this sector.

Furthermore, electroceutical devices have seen notable technological advancements, resulting in smaller, more flexible, and efficient products. Advancements include compatibility with MRI scans, eliminating the inconvenience of device removal during imaging procedures. Moreover, the introduction of rechargeable batteries and wireless capabilities enhances patient comfort and convenience. These innovations address key concerns such as patient mobility and ease of use, driving the demand among both patients and physicians. As a result, the electroceuticals market is expected to experience significant growth as these advancements make these devices more accessible, user-friendly, and capable of delivering effective treatments for various medical conditions, ultimately improving patient outcomes and quality of life.

The global electroceuticals market is segmented into product, device type, application, end user, and region. On the basis of product, the market is categorized into cardiac pacemakers & implantable cardioverter defibrillators, cochlear implants, spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, sacral nerve stimulators, and others. Depending on device type, it is bifurcated into implantable devices and non-invasive devices. On the basis of application, it is classified into arrhythmia, sensorineural hearing loss, epilepsy, parkinson's disease, and others. By end user, it is segregated into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and Latin America (Brazil, Colombia, Argentina, and rest of Latin America), and Middle East & Africa (GCC, South Africa, North Africa, and rest of Middle East & Africa).

The key players that operate in the electroceuticals market are Medtronic, Abbott Laboratorie, Boston Scientific Corporation; Cochlear Ltd., LivaNova PLC, Biotronik SE & Co. KG, ElectroCore, Inc., Sonova, Nevro Corp., and Stimwave LLC. The key players have adopted product launch, product development, and product approval as the key strategies to strengthen their foothold in the competitive market

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electroceuticals market analysis from 2022 to 2032 to identify the prevailing electroceuticals market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the electroceuticals market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global electroceuticals market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Expanded list for Company Profiles
• Historic market data
• Reimbursement Scenario

Key Market Segments

By Product

• Cardiac Pacemakers and Implantable Cardioverter Defibrillators
• Cochlear Implants
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Others

By Device Type

• Implantable Devices
• Non-invasive Devices

By Application

• Arrhythmia
• Sensorineural Hearing Loss
• Epilepsy
• Parkinson's Disease
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Colombia
  • Argentina
  • Rest Of La
• Middle East and Africa
  • Gcc
  • South Africa
  • North Africa
  • Rest Of Mea

Key Market Players:

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Cochlear Limited
• LivaNova PLC
• Biotronik SE & Co. KG
• electroCore, Inc.
• Sonova Holding AG
• Nevro Corporation
• Oticon Medical AB

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
• 3.4. Market dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: ELECTROCEUTICALS MARKET, BY PRODUCT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Cardiac Pacemakers and Implantable Cardioverter Defibrillators
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Cochlear Implants
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Spinal Cord Stimulators
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Deep Brain Stimulators
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country
• 4.6. Vagus Nerve Stimulators
  • 4.6.1. Key market trends, growth factors and opportunities
  • 4.6.2. Market size and forecast, by region
  • 4.6.3. Market share analysis by country
• 4.7. Sacral Nerve Stimulators
  • 4.7.1. Key market trends, growth factors and opportunities
  • 4.7.2. Market size and forecast, by region
  • 4.7.3. Market share analysis by country
• 4.8. Others
  • 4.8.1. Key market trends, growth factors and opportunities
  • 4.8.2. Market size and forecast, by region
  • 4.8.3. Market share analysis by country

CHAPTER 5: ELECTROCEUTICALS MARKET, BY DEVICE TYPE

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Implantable Devices
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Non-invasive Devices
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country

CHAPTER 6: ELECTROCEUTICALS MARKET, BY APPLICATION

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Arrhythmia
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Sensorineural Hearing Loss
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Epilepsy
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country
• 6.5. Parkinson's Disease
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by region
  • 6.5.3. Market share analysis by country
• 6.6. Others
  • 6.6.1. Key market trends, growth factors and opportunities
  • 6.6.2. Market size and forecast, by region
  • 6.6.3. Market share analysis by country

CHAPTER 7: ELECTROCEUTICALS MARKET, BY END USER

• 7.1. Overview
  • 7.1.1. Market size and forecast
• 7.2. Hospitals
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by region
  • 7.2.3. Market share analysis by country
• 7.3. Ambulatory Surgical Centers
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by region
  • 7.3.3. Market share analysis by country
• 7.4. Others
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by region
  • 7.4.3. Market share analysis by country

CHAPTER 8: ELECTROCEUTICALS MARKET, BY REGION

• 8.1. Overview
  • 8.1.1. Market size and forecast By Region
• 8.2. North America
  • 8.2.1. Key market trends, growth factors and opportunities
  • 8.2.2. Market size and forecast, by Product
  • 8.2.3. Market size and forecast, by Device Type
  • 8.2.4. Market size and forecast, by Application
  • 8.2.5. Market size and forecast, by End User
  • 8.2.6. Market size and forecast, by country
    • 8.2.6.1. U.S.
    • 8.2.6.1.1. Market size and forecast, by Product
    • 8.2.6.1.2. Market size and forecast, by Device Type
    • 8.2.6.1.3. Market size and forecast, by Application
    • 8.2.6.1.4. Market size and forecast, by End User
    • 8.2.6.2. Canada
    • 8.2.6.2.1. Market size and forecast, by Product
    • 8.2.6.2.2. Market size and forecast, by Device Type
    • 8.2.6.2.3. Market size and forecast, by Application
    • 8.2.6.2.4. Market size and forecast, by End User
    • 8.2.6.3. Mexico
    • 8.2.6.3.1. Market size and forecast, by Product
    • 8.2.6.3.2. Market size and forecast, by Device Type
    • 8.2.6.3.3. Market size and forecast, by Application
    • 8.2.6.3.4. Market size and forecast, by End User
• 8.3. Europe
  • 8.3.1. Key market trends, growth factors and opportunities
  • 8.3.2. Market size and forecast, by Product
  • 8.3.3. Market size and forecast, by Device Type
  • 8.3.4. Market size and forecast, by Application
  • 8.3.5. Market size and forecast, by End User
  • 8.3.6. Market size and forecast, by country
    • 8.3.6.1. Germany
    • 8.3.6.1.1. Market size and forecast, by Product
    • 8.3.6.1.2. Market size and forecast, by Device Type
    • 8.3.6.1.3. Market size and forecast, by Application
    • 8.3.6.1.4. Market size and forecast, by End User
    • 8.3.6.2. France
    • 8.3.6.2.1. Market size and forecast, by Product
    • 8.3.6.2.2. Market size and forecast, by Device Type
    • 8.3.6.2.3. Market size and forecast, by Application
    • 8.3.6.2.4. Market size and forecast, by End User
    • 8.3.6.3. UK
    • 8.3.6.3.1. Market size and forecast, by Product
    • 8.3.6.3.2. Market size and forecast, by Device Type
    • 8.3.6.3.3. Market size and forecast, by Application
    • 8.3.6.3.4. Market size and forecast, by End User
    • 8.3.6.4. Italy
    • 8.3.6.4.1. Market size and forecast, by Product
    • 8.3.6.4.2. Market size and forecast, by Device Type
    • 8.3.6.4.3. Market size and forecast, by Application
    • 8.3.6.4.4. Market size and forecast, by End User
    • 8.3.6.5. Spain
    • 8.3.6.5.1. Market size and forecast, by Product
    • 8.3.6.5.2. Market size and forecast, by Device Type
    • 8.3.6.5.3. Market size and forecast, by Application
    • 8.3.6.5.4. Market size and forecast, by End User
    • 8.3.6.6. Rest of Europe
    • 8.3.6.6.1. Market size and forecast, by Product
    • 8.3.6.6.2. Market size and forecast, by Device Type
    • 8.3.6.6.3. Market size and forecast, by Application
    • 8.3.6.6.4. Market size and forecast, by End User
• 8.4. Asia-Pacific
  • 8.4.1. Key market trends, growth factors and opportunities
  • 8.4.2. Market size and forecast, by Product
  • 8.4.3. Market size and forecast, by Device Type
  • 8.4.4. Market size and forecast, by Application
  • 8.4.5. Market size and forecast, by End User
  • 8.4.6. Market size and forecast, by country
    • 8.4.6.1. Japan
    • 8.4.6.1.1. Market size and forecast, by Product
    • 8.4.6.1.2. Market size and forecast, by Device Type
    • 8.4.6.1.3. Market size and forecast, by Application
    • 8.4.6.1.4. Market size and forecast, by End User
    • 8.4.6.2. China
    • 8.4.6.2.1. Market size and forecast, by Product
    • 8.4.6.2.2. Market size and forecast, by Device Type
    • 8.4.6.2.3. Market size and forecast, by Application
    • 8.4.6.2.4. Market size and forecast, by End User
    • 8.4.6.3. India
    • 8.4.6.3.1. Market size and forecast, by Product
    • 8.4.6.3.2. Market size and forecast, by Device Type
    • 8.4.6.3.3. Market size and forecast, by Application
    • 8.4.6.3.4. Market size and forecast, by End User
    • 8.4.6.4. Australia
    • 8.4.6.4.1. Market size and forecast, by Product
    • 8.4.6.4.2. Market size and forecast, by Device Type
    • 8.4.6.4.3. Market size and forecast, by Application
    • 8.4.6.4.4. Market size and forecast, by End User
    • 8.4.6.5. South Korea
    • 8.4.6.5.1. Market size and forecast, by Product
    • 8.4.6.5.2. Market size and forecast, by Device Type
    • 8.4.6.5.3. Market size and forecast, by Application
    • 8.4.6.5.4. Market size and forecast, by End User
    • 8.4.6.6. Rest of Asia-Pacific
    • 8.4.6.6.1. Market size and forecast, by Product
    • 8.4.6.6.2. Market size and forecast, by Device Type
    • 8.4.6.6.3. Market size and forecast, by Application
    • 8.4.6.6.4. Market size and forecast, by End User
• 8.5. Latin America
  • 8.5.1. Key market trends, growth factors and opportunities
  • 8.5.2. Market size and forecast, by Product
  • 8.5.3. Market size and forecast, by Device Type
  • 8.5.4. Market size and forecast, by Application
  • 8.5.5. Market size and forecast, by End User
  • 8.5.6. Market size and forecast, by country
    • 8.5.6.1. Brazil
    • 8.5.6.1.1. Market size and forecast, by Product
    • 8.5.6.1.2. Market size and forecast, by Device Type
    • 8.5.6.1.3. Market size and forecast, by Application
    • 8.5.6.1.4. Market size and forecast, by End User
    • 8.5.6.2. Colombia
    • 8.5.6.2.1. Market size and forecast, by Product
    • 8.5.6.2.2. Market size and forecast, by Device Type
    • 8.5.6.2.3. Market size and forecast, by Application
    • 8.5.6.2.4. Market size and forecast, by End User
    • 8.5.6.3. Argentina
    • 8.5.6.3.1. Market size and forecast, by Product
    • 8.5.6.3.2. Market size and forecast, by Device Type
    • 8.5.6.3.3. Market size and forecast, by Application
    • 8.5.6.3.4. Market size and forecast, by End User
    • 8.5.6.4. Rest Of La
    • 8.5.6.4.1. Market size and forecast, by Product
    • 8.5.6.4.2. Market size and forecast, by Device Type
    • 8.5.6.4.3. Market size and forecast, by Application
    • 8.5.6.4.4. Market size and forecast, by End User
• 8.6. Middle East and Africa
  • 8.6.1. Key market trends, growth factors and opportunities
  • 8.6.2. Market size and forecast, by Product
  • 8.6.3. Market size and forecast, by Device Type
  • 8.6.4. Market size and forecast, by Application
  • 8.6.5. Market size and forecast, by End User
  • 8.6.6. Market size and forecast, by country
    • 8.6.6.1. Gcc
    • 8.6.6.1.1. Market size and forecast, by Product
    • 8.6.6.1.2. Market size and forecast, by Device Type
    • 8.6.6.1.3. Market size and forecast, by Application
    • 8.6.6.1.4. Market size and forecast, by End User
    • 8.6.6.2. South Africa
    • 8.6.6.2.1. Market size and forecast, by Product
    • 8.6.6.2.2. Market size and forecast, by Device Type
    • 8.6.6.2.3. Market size and forecast, by Application
    • 8.6.6.2.4. Market size and forecast, by End User
    • 8.6.6.3. North Africa
    • 8.6.6.3.1. Market size and forecast, by Product
    • 8.6.6.3.2. Market size and forecast, by Device Type
    • 8.6.6.3.3. Market size and forecast, by Application
    • 8.6.6.3.4. Market size and forecast, by End User
    • 8.6.6.4. Rest Of Mea
    • 8.6.6.4.1. Market size and forecast, by Product
    • 8.6.6.4.2. Market size and forecast, by Device Type
    • 8.6.6.4.3. Market size and forecast, by Application
    • 8.6.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

• 9.1. Introduction
• 9.2. Top winning strategies
• 9.3. Product mapping of top 10 player
• 9.4. Competitive dashboard
• 9.5. Competitive heatmap
• 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

• 10.1. Medtronic
  • 10.1.1. Company overview
  • 10.1.2. Key executives
  • 10.1.3. Company snapshot
  • 10.1.4. Operating business segments
  • 10.1.5. Product portfolio
  • 10.1.6. Business performance
  • 10.1.7. Key strategic moves and developments
• 10.2. Abbott Laboratories
  • 10.2.1. Company overview
  • 10.2.2. Key executives
  • 10.2.3. Company snapshot
  • 10.2.4. Operating business segments
  • 10.2.5. Product portfolio
  • 10.2.6. Business performance
  • 10.2.7. Key strategic moves and developments
• 10.3. Boston Scientific Corporation
  • 10.3.1. Company overview
  • 10.3.2. Key executives
  • 10.3.3. Company snapshot
  • 10.3.4. Operating business segments
  • 10.3.5. Product portfolio
  • 10.3.6. Business performance
  • 10.3.7. Key strategic moves and developments
• 10.4. Cochlear Limited
  • 10.4.1. Company overview
  • 10.4.2. Key executives
  • 10.4.3. Company snapshot
  • 10.4.4. Operating business segments
  • 10.4.5. Product portfolio
  • 10.4.6. Business performance
  • 10.4.7. Key strategic moves and developments
• 10.5. LivaNova PLC
  • 10.5.1. Company overview
  • 10.5.2. Key executives
  • 10.5.3. Company snapshot
  • 10.5.4. Operating business segments
  • 10.5.5. Product portfolio
  • 10.5.6. Business performance
  • 10.5.7. Key strategic moves and developments
• 10.6. Biotronik SE & Co. KG
  • 10.6.1. Company overview
  • 10.6.2. Key executives
  • 10.6.3. Company snapshot
  • 10.6.4. Operating business segments
  • 10.6.5. Product portfolio
  • 10.6.6. Business performance
  • 10.6.7. Key strategic moves and developments
• 10.7. electroCore, Inc.
  • 10.7.1. Company overview
  • 10.7.2. Key executives
  • 10.7.3. Company snapshot
  • 10.7.4. Operating business segments
  • 10.7.5. Product portfolio
  • 10.7.6. Business performance
  • 10.7.7. Key strategic moves and developments
• 10.8. Sonova Holding AG
  • 10.8.1. Company overview
  • 10.8.2. Key executives
  • 10.8.3. Company snapshot
  • 10.8.4. Operating business segments
  • 10.8.5. Product portfolio
  • 10.8.6. Business performance
  • 10.8.7. Key strategic moves and developments
• 10.9. Nevro Corporation
  • 10.9.1. Company overview
  • 10.9.2. Key executives
  • 10.9.3. Company snapshot
  • 10.9.4. Operating business segments
  • 10.9.5. Product portfolio
  • 10.9.6. Business performance
  • 10.9.7. Key strategic moves and developments
• 10.10. Oticon Medical AB
  • 10.10.1. Company overview
  • 10.10.2. Key executives
  • 10.10.3. Company snapshot
  • 10.10.4. Operating business segments
  • 10.10.5. Product portfolio
  • 10.10.6. Business performance
  • 10.10.7. Key strategic moves and developments

관련자료